- Home
- TMUS vs MRK Comparison
TMUS vs MRK Comparison
Compare TMUS & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMUS
- MRK
- Stock Information
- Founded
- TMUS 1994
- MRK 2000
- Country
- TMUS United States
- MRK United States
- Employees
- TMUS N/A
- MRK N/A
- Industry
- TMUS Telecommunications Equipment
- MRK Biotechnology: Pharmaceutical Preparations
- Sector
- TMUS Telecommunications
- MRK Health Care
- Exchange
- TMUS Nasdaq
- MRK Nasdaq
- Market Cap
- TMUS 258.1B
- MRK 218.8B
- IPO Year
- TMUS N/A
- MRK N/A
- Fundamental
- Price
- TMUS $229.96
- MRK $86.42
- Analyst Decision
- TMUS Buy
- MRK Buy
- Analyst Count
- TMUS 22
- MRK 15
- Target Price
- TMUS $261.62
- MRK $105.14
- AVG Volume (30 Days)
- TMUS 4.2M
- MRK 13.0M
- Earning Date
- TMUS 10-23-2025
- MRK 10-30-2025
- Dividend Yield
- TMUS 1.53%
- MRK 3.82%
- EPS Growth
- TMUS 32.79
- MRK 20.41
- EPS
- TMUS 10.59
- MRK 6.49
- Revenue
- TMUS $84,052,000,000.00
- MRK $63,616,000,000.00
- Revenue This Year
- TMUS $9.50
- MRK $1.84
- Revenue Next Year
- TMUS $6.01
- MRK $5.24
- P/E Ratio
- TMUS $21.65
- MRK $13.07
- Revenue Growth
- TMUS 6.27
- MRK 1.82
- 52 Week Low
- TMUS $208.39
- MRK $73.31
- 52 Week High
- TMUS $276.49
- MRK $110.19
- Technical
- Relative Strength Index (RSI)
- TMUS 44.76
- MRK 56.21
- Support Level
- TMUS $225.25
- MRK $83.16
- Resistance Level
- TMUS $230.06
- MRK $85.50
- Average True Range (ATR)
- TMUS 4.56
- MRK 2.08
- MACD
- TMUS 0.48
- MRK -0.15
- Stochastic Oscillator
- TMUS 41.40
- MRK 41.56
About TMUS T-Mobile US Inc.
Deutsche Telekom merged its T-Mobile USA unit with prepaid specialist MetroPCS in 2013, and that firm merged with Sprint in 2020, creating the second-largest wireless carrier in the US. T-Mobile now serves 80 million postpaid and 25 million prepaid phone customers, equal to around 30% of the US retail wireless market. The firm entered the fixed-wireless broadband market aggressively in 2021 and now serves 7 million residential and business customers. In addition, T-Mobile provides wholesale services to resellers.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).